Skip to main content
. 2014 Feb 24;7:353–363. doi: 10.2147/OTT.S56115

Figure 4.

Figure 4

(A and B) The antiproliferative effect of celecoxib combined with gefitinib was evaluated in HepG2 multicellular spheroids and monolayer cells. (A) HepG2 multicellular spheroids; (B) HepG2 monolayer cells. Gefitinib (5 μmol/L) increased the inhibitory effect of celecoxib.

Notes: *P<0.05, gefitinib plus celecoxib versus celecoxib. All sample measurements were replicated five times.